According to Emergen Research, the global specialty enzymes market size was USD 4.45 Billion in 2020 and is expected to reach USD 8.21 Billion in 2028 and register a revenue CAGR of 8.0% during the forecast period, 2021-2028.
Emergen Research has published its latest report titled “Specialty Enzymes Market By Source (Plants, Microorganisms, Animals), By Application (Biotechnology R&D, Pharmaceutical, Diagnostic), By Type (Proteases, Polymerases & nucleases, Carbohydrase, Lipases), and By Region, Forecast to 2028”
According to Emergen Research, the global specialty enzymes market size was USD 4.45 Billion in 2020 and is expected to reach USD 8.21 Billion in 2028 and register a revenue CAGR of 8.0% during the forecast period, 2021-2028.
Market Dynamics:
Specialty enzymes are proteins that act as biocatalysts in pharmaceutical and diagnostic procedures to speed up reactions and generate the desired outcomes. These enzymes are important diagnostic tools for the treatment of diseases like cardiovascular disease, cancer, and lysosomal disorders and increasing use of specialty enzymes in molecular biology research and in pharmaceutical industry are key factors expected to drive global market revenue growth. These enzymes catalyze the formation of ribonucleic acid (RNA) polymers and deoxyribonucleic acid (DNA), as they are required for nucleic acid processing, including repair, recombination, replication, and transcription. In addition, increasing number of research and development activities in biotechnology R&D, advancement in green chemistry, implementation of advanced technologies in the pharmaceutical sector, and rising demand for effective therapeutics and pure pharmaceutical drugs are some factors expected to positively impact specialty enzymes market revenue growth throughout the forecast period.
However, high investments on R&D activities, unfavorable government regulations on the maintaining operational temperature and pH of specialty enzymes and poor reimbursement medical policies are some factors expected to restrain specialty enzymes market to a certain extent over the forecast period.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/519
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Pharmaceutical Segment Revenue to Expand at a Rapid CAGR:
Pharmaceutical segment is expected to register a rapid CAGR among other segments in the market throughout the forecast period owing to increasing usage of enzymes in therapies for the treatment of cardiovascular diseases and cancer, growing private and government preference in the production of pharmaceutical drug formulations, and rising application of specialty enzymes in pharmaceuticals sector.
Polymerases & Nucleases Segment to Register Significant Revenue Growth:
Polymerases & nucleases segment is expected to incline rapidly in the wearable injectors market over the forecast period due to rising adoption of genetic testing, and increasing application of polymerases and nucleases in DNA sequencing and DNA amplification. These enzymes play important part in various DNA repair processes, including nucleotide excision repair, DNA replication, mismatch repair, base excision repair, and double strand break repair.
North America to Account for Largest Revenue Share:
North America is expected to register a larger revenue share contribution in the global market throughout the forecast period due to increasing government investments in biotechnology industries, advancements in enzyme engineering and increasing number of patients suffering from digestive disorders. In addition, presence of biopharmaceutical companies and available of advanced therapeutics for the treatment of chronic diseases are some other factors expected to fuel market growth in the countries of the region over the forecast period.
Buy your Exclusive copy@ https://www.emergenresearch.com/select-license/519
Major Companies in the Market Include:
- BASF SE
- Novozymes A/S
- Roche Holding AG
- DuPont
- Codexis
- Dyadic International, Inc.
- Advanced Enzyme
- Amano Enzyme
- Sanofi
- Biocatalysts Ltd.
For the purpose of this report, Emergen Research has segmented the global specialty enzymes market on the basis of source, application, type, and region:
Source Outlook (Revenue, USD Billion; 2021–2028)
- Plants
- Microorganisms
- Animals
Application Outlook (Revenue, USD Billion; 2021–2028)
- Biotechnology R&D
- Pharmaceutical
- Diagnostic
Type Outlook (Revenue, USD Billion; 2021–2028)
- Proteases
- Polymerases & nucleases
- Carbohydrase
- Lipases
- Other enzymes
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/specialty-enzymes-market
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of MEA
Insights into our Other Published Healthcare Reports:
Wound Cleanser Products Market Size Worth USD 1.97 Billion By 2027 | CAGR of 3.5%
Carrier Screening Market Size Worth USD 6.13 Billion By 2027 | CAGR of 17.4%
Human Microbiome Therapeutics Market To Be Worth USD 1,098.4 Million by 2027. Key participants include: Finch Therapeutics, Biotagenics Inc., Commense Inc, DermBiont, Inc, Others
Healthcare Chatbots Market To Be Worth USD 594.8 Million by 2027 | CAGR of 20.3%
Interoperability Solutions in Healthcare Market Size Worth USD 5.29 Billion By 2027 | CAGR of 11.1%
Cell-Free DNA (cfDNA) Testing Market Size Worth USD 22.41 Billion by 2027 | CAGR of 26.2%
Prefilled Syringes Market Size Worth USD 9.11 Billion by 2027 | CAGR of 8.9%
Assisted Reproductive Technology (ART) Market Size Worth USD 50.32 Billion by 2027 | CAGR of 9.3%
Alopecia Market Size Worth USD 5,250.8 Million by 2027 | CAGR of 8.9%
Synthetic Blood Substitutes Market Size Worth USD 15.40 Billion by 2027 | CAGR of 18.5%
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
Full Press Release@ https://www.emergenresearch.com/press-release/global-specialty-enzymes-market